GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arterra Bioscience SpA (MIL:ARBS) » Definitions » EV-to-FCF

Arterra Bioscience SpA (MIL:ARBS) EV-to-FCF : 15.70 (As of Mar. 30, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Arterra Bioscience SpA EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Arterra Bioscience SpA's Enterprise Value is €11.64 Mil. Arterra Bioscience SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €0.74 Mil. Therefore, Arterra Bioscience SpA's EV-to-FCF for today is 15.70.

The historical rank and industry rank for Arterra Bioscience SpA's EV-to-FCF or its related term are showing as below:

MIL:ARBS' s EV-to-FCF Range Over the Past 10 Years
Min: 3.82   Med: 12.58   Max: 240.93
Current: 14.3

During the past 7 years, the highest EV-to-FCF of Arterra Bioscience SpA was 240.93. The lowest was 3.82. And the median was 12.58.

MIL:ARBS's EV-to-FCF is ranked worse than
62.12% of 433 companies
in the Biotechnology industry
Industry Median: 3.31 vs MIL:ARBS: 14.30

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-30), Arterra Bioscience SpA's stock price is €2.26. Arterra Bioscience SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.206. Therefore, Arterra Bioscience SpA's PE Ratio (TTM) for today is 10.97.


Arterra Bioscience SpA EV-to-FCF Historical Data

The historical data trend for Arterra Bioscience SpA's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arterra Bioscience SpA EV-to-FCF Chart

Arterra Bioscience SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial 163.86 153.89 19.17 6.85 7.97

Arterra Bioscience SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 6.85 - 7.97 -

Competitive Comparison of Arterra Bioscience SpA's EV-to-FCF

For the Biotechnology subindustry, Arterra Bioscience SpA's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arterra Bioscience SpA's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arterra Bioscience SpA's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Arterra Bioscience SpA's EV-to-FCF falls into.


;
;

Arterra Bioscience SpA EV-to-FCF Calculation

Arterra Bioscience SpA's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=11.637/0.741
=15.70

Arterra Bioscience SpA's current Enterprise Value is €11.64 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arterra Bioscience SpA's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €0.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arterra Bioscience SpA  (MIL:ARBS) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Arterra Bioscience SpA's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.26/0.206
=10.97

Arterra Bioscience SpA's share price for today is €2.26.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Arterra Bioscience SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €0.206.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Arterra Bioscience SpA EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Arterra Bioscience SpA's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Arterra Bioscience SpA Business Description

Traded in Other Exchanges
N/A
Address
via Benedetto Brin, 69, Napoli, ITA, 80142
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.

Arterra Bioscience SpA Headlines

No Headlines